BACKGROUND: GRACE, TIMI, Zwolle, and CADILLAC are risk scores designed for predicting short-term outcome after acute coronary syndromes. The aim of our study was to test their utility for a prognosis of 5-year survival in a "real-life" population of patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interventions (pPCI). METHODS: Our registry consisted of consecutive patients with STEMI treated with pPCI. Five-year follow-up was performed with all-cause mortality as the end-point. RESULTS: Out of 505 patients (mean age 58.6±11.3 years) 32 died during the first 30 days (6.3%) and an additional 74 within 5 years (15.6%). PCI was successful in 95.2% (n=481). Prognostic values (c statistics) for predicting 5-year mortality equaled: 0.742 (CI 0.69-0.79) for the GRACE risk score, 0.727 (CI 0.67-0.78) for TIMI, 0.72 (CI 0.67-0.77) for Zwolle, and 0.687 (CI 0.63-0.74) for CADILLAC. In a univariate analysis all the scores were associated with the 5-year outcome. CONCLUSIONS: GRACE, TIMI, and Zwolle risk scores predicted well 5-year all-cause mortality in patients with STEMI treated with pPCI. Our data show that the usefulness of initial bedside risk assessment can be further extended for long-term follow-up.
BACKGROUND: GRACE, TIMI, Zwolle, and CADILLAC are risk scores designed for predicting short-term outcome after acute coronary syndromes. The aim of our study was to test their utility for a prognosis of 5-year survival in a "real-life" population of patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interventions (pPCI). METHODS: Our registry consisted of consecutive patients with STEMI treated with pPCI. Five-year follow-up was performed with all-cause mortality as the end-point. RESULTS: Out of 505 patients (mean age 58.6±11.3 years) 32 died during the first 30 days (6.3%) and an additional 74 within 5 years (15.6%). PCI was successful in 95.2% (n=481). Prognostic values (c statistics) for predicting 5-year mortality equaled: 0.742 (CI 0.69-0.79) for the GRACE risk score, 0.727 (CI 0.67-0.78) for TIMI, 0.72 (CI 0.67-0.77) for Zwolle, and 0.687 (CI 0.63-0.74) for CADILLAC. In a univariate analysis all the scores were associated with the 5-year outcome. CONCLUSIONS: GRACE, TIMI, and Zwolle risk scores predicted well 5-year all-cause mortality in patients with STEMI treated with pPCI. Our data show that the usefulness of initial bedside risk assessment can be further extended for long-term follow-up.
Authors: Alexander D Simms; Philip D Batin; John Kurian; Nigel Durham; Christopher P Gale Journal: J Geriatr Cardiol Date: 2012-06 Impact factor: 3.327
Authors: Simona Littnerova; Petr Kala; Jiri Jarkovsky; Lenka Kubkova; Krystyna Prymusova; Petr Kubena; Martin Tesak; Ondrej Toman; Martin Poloczek; Jindrich Spinar; Ladislav Dusek; Jiri Parenica Journal: PLoS One Date: 2015-04-20 Impact factor: 3.240
Authors: Anna Szpakowicz; Marek Kiliszek; Witold Pepinski; Ewa Waszkiewicz; Maria Franaszczyk; Malgorzata Skawronska; Rafal Ploski; Anna Niemcunowicz-Janica; Beata Burzynska; Dorota Tulacz; Agata Maciejak; Marcin Jakub Kaminski; Grzegorz Opolski; Wlodzimierz Jerzy Musial; Karol Adam Kaminski Journal: PLoS One Date: 2015-06-18 Impact factor: 3.240
Authors: Luis C L Correia; Guilherme Garcia; Felipe Kalil; Felipe Ferreira; Manuela Carvalhal; Ruan Oliveira; André Silva; Isis Vasconcelos; Caio Henri; Márcia Noya-Rabelo Journal: Arq Bras Cardiol Date: 2014-07-15 Impact factor: 2.000
Authors: Zainali S Chunawala; Michael E Hall; Sameer Arora; Xuming Dai; Venu Menon; Sidney C Smith; Kunihiro Matsushita; Melissa C Caughey Journal: Eur Heart J Acute Cardiovasc Care Date: 2021-10-27